Effect of Continuous Positive Airway Pressure on Blood Pressure

Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea.

Obstructive sleep apnea (OSA) is a very common risk factor for hypertension, and continuous positive airway pressure (CPAP) has been widely used to treat OSA. We conducted a meta-analysis of randomized, controlled trials to evaluate the effects of CPAP on blood pressure, reported as either a primary or secondary end point, among patients with OSA. Studies were retrieved by searching Medline (Ja...

Effect of continuous positive airway pressure on blood pressure : a placebo trial.

This study examined the effect of continuous positive airway pressure (CPAP) treatment on blood pressure in patients with obstructive sleep apnea. Thirty-nine patients with sleep apnea were studied. Ambulatory blood pressure monitoring was obtained before and after patients were randomized to receive either 1 week of CPAP or placebo CPAP (CPAP administered at ineffective pressure). Blood pressu...

Intraocular Pressure during Continuous Positive Airway Pressure

Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea.

STUDY OBJECTIVES Continuous positive airway pressure (CPAP) therapy has become the treatment of choice for obstructive sleep apnea (OSA). However, the efficacy of CPAP therapy has not been evaluated against a suitable control. We investigated the effectiveness of CPAP therapy in improving sleep quality in patients with OSA. We hypothesized that CPAP improves sleep quality. PATIENTS Forty-eigh...

Effect of continuous positive airway pressure on inflammatory markers.

www.chestpubs.org that D lco is likely to be an important and relevant prognosis factor in patients with PAH-SSc. ILD, PH due to ILD, and PAH are not the sole causes of D lco impairment in patients with SSc. Nevertheless, for clinical practice, it seems important to highlight the fact that a markedly impaired D lco , 35% to 40% of predicted value in patients with PAH-SSc may be associated with ...